RCKT - Wall Street Estimates - Rocket Pharmaceuticals, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 9.17

-2.96 %

$ 978 M

Market Cap

-3.36

P/E

Price Target Average

320.94%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

47.39%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Rocket Pharmaceuticals, Inc.

Wall Street analysts predict an average 1-year price target for RCKT of $38.6 , with forecasts ranging from a low of $32 to a high of $45 .

RCKT Lowest Price Target Wall Street Target

32 USD 248.96%

RCKT Average Price Target Wall Street Target

38.6 USD 320.94%

RCKT Highest Price Target Wall Street Target

45 USD 390.73%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free